Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study.
<h4>Background</h4>Pneumonia is a significant cause of morbidity and mortality among adults globally. This retrospective cohort analysis assessed the pneumonia burden and related healthcare resource utilization and costs in the at-risk (low, medium, and high-risk) adult patients in Dubai...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0256856 |
| _version_ | 1818401653864267776 |
|---|---|
| author | Sara Ahmad Mohammad Al Dallal Mohamed Farghaly Ahmed Ghorab Mostafa Elaassar Hammam Haridy Nancy Awad Badarinath Chickballapur Ramachandrachar Ashok Natarajan |
| author_facet | Sara Ahmad Mohammad Al Dallal Mohamed Farghaly Ahmed Ghorab Mostafa Elaassar Hammam Haridy Nancy Awad Badarinath Chickballapur Ramachandrachar Ashok Natarajan |
| author_sort | Sara Ahmad Mohammad Al Dallal |
| collection | DOAJ |
| description | <h4>Background</h4>Pneumonia is a significant cause of morbidity and mortality among adults globally. This retrospective cohort analysis assessed the pneumonia burden and related healthcare resource utilization and costs in the at-risk (low, medium, and high-risk) adult patients in Dubai, United Arab Emirates (UAE).<h4>Methods</h4>The claims data from January 1, 2014 to June 30, 2019 were extracted from the Dubai Real-World Claims Database for patients, aged ≥18 year, having at least 1 pneumonia claim. Data for the inpatient, outpatient and emergency visits were assessed for 12-months, before (pre-index) and after (follow-up) a pneumonia episode. Healthcare costs were calculated based on dollar value of 2020.<h4>Results</h4>Total 48,562 records of eligible patients were analyzed (mean age = 39.9 years; low [62.1%], medium [36.2%] and high [1.7%] risk cohorts). Mean all-cause healthcare costs were approximately >45% higher in the follow-up period (1,947 USD/patient) versus pre-index period (1,327 USD/patient). During follow-up period, the mean annual pneumonia incidence rate was 1.3 episodes, with a similar pattern across all cohorts. Overall, mean claims and costs (USD) per patient (all-cause) were highest in the high-risk cohort in the follow-up period (claims: overall, 11.6; high-risk, 22.0; medium-risk, 13.9; low-risk, 9.9; costs: high-risk, 14,184; medium-risk, 2,240; low-risk, 1,388). Similarly, the mean pneumonia-related costs (USD) per patient were highest for the high-risk cohort (overall: 1,305; high-risk, 10,207; medium-risk, 1,283; low-risk, 882), however, the claims were similar across cohorts (claims/patient: overall: 2.0; high-risk, 1.9; medium-risk, 2.2; low-risk, 1.9). Most all-cause and pneumonia-related costs were due to inpatient visits (4,901 and 4,818 USD respectively), while outpatient (1,232 and 166 USD respectively) and emergency visits (347 and 206 USD respectively) contributed significantly lesser.<h4>Conclusions</h4>Pneumonia imposes a significant healthcare burden in the UAE, especially in the high-risk patients with severe comorbidities. These findings would guide clinicians and policy makers to make informed decisions. |
| first_indexed | 2024-12-14T07:55:54Z |
| format | Article |
| id | doaj.art-adf3f575d3b9441f9cb45c06c79bb7c3 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-14T07:55:54Z |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-adf3f575d3b9441f9cb45c06c79bb7c32022-12-21T23:10:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01169e025685610.1371/journal.pone.0256856Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study.Sara Ahmad Mohammad Al DallalMohamed FarghalyAhmed GhorabMostafa ElaassarHammam HaridyNancy AwadBadarinath Chickballapur RamachandracharAshok Natarajan<h4>Background</h4>Pneumonia is a significant cause of morbidity and mortality among adults globally. This retrospective cohort analysis assessed the pneumonia burden and related healthcare resource utilization and costs in the at-risk (low, medium, and high-risk) adult patients in Dubai, United Arab Emirates (UAE).<h4>Methods</h4>The claims data from January 1, 2014 to June 30, 2019 were extracted from the Dubai Real-World Claims Database for patients, aged ≥18 year, having at least 1 pneumonia claim. Data for the inpatient, outpatient and emergency visits were assessed for 12-months, before (pre-index) and after (follow-up) a pneumonia episode. Healthcare costs were calculated based on dollar value of 2020.<h4>Results</h4>Total 48,562 records of eligible patients were analyzed (mean age = 39.9 years; low [62.1%], medium [36.2%] and high [1.7%] risk cohorts). Mean all-cause healthcare costs were approximately >45% higher in the follow-up period (1,947 USD/patient) versus pre-index period (1,327 USD/patient). During follow-up period, the mean annual pneumonia incidence rate was 1.3 episodes, with a similar pattern across all cohorts. Overall, mean claims and costs (USD) per patient (all-cause) were highest in the high-risk cohort in the follow-up period (claims: overall, 11.6; high-risk, 22.0; medium-risk, 13.9; low-risk, 9.9; costs: high-risk, 14,184; medium-risk, 2,240; low-risk, 1,388). Similarly, the mean pneumonia-related costs (USD) per patient were highest for the high-risk cohort (overall: 1,305; high-risk, 10,207; medium-risk, 1,283; low-risk, 882), however, the claims were similar across cohorts (claims/patient: overall: 2.0; high-risk, 1.9; medium-risk, 2.2; low-risk, 1.9). Most all-cause and pneumonia-related costs were due to inpatient visits (4,901 and 4,818 USD respectively), while outpatient (1,232 and 166 USD respectively) and emergency visits (347 and 206 USD respectively) contributed significantly lesser.<h4>Conclusions</h4>Pneumonia imposes a significant healthcare burden in the UAE, especially in the high-risk patients with severe comorbidities. These findings would guide clinicians and policy makers to make informed decisions.https://doi.org/10.1371/journal.pone.0256856 |
| spellingShingle | Sara Ahmad Mohammad Al Dallal Mohamed Farghaly Ahmed Ghorab Mostafa Elaassar Hammam Haridy Nancy Awad Badarinath Chickballapur Ramachandrachar Ashok Natarajan Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study. PLoS ONE |
| title | Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study. |
| title_full | Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study. |
| title_fullStr | Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study. |
| title_full_unstemmed | Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study. |
| title_short | Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study. |
| title_sort | real world evaluation of costs of illness for pneumonia in adult patients in dubai a claims database study |
| url | https://doi.org/10.1371/journal.pone.0256856 |
| work_keys_str_mv | AT saraahmadmohammadaldallal realworldevaluationofcostsofillnessforpneumoniainadultpatientsindubaiaclaimsdatabasestudy AT mohamedfarghaly realworldevaluationofcostsofillnessforpneumoniainadultpatientsindubaiaclaimsdatabasestudy AT ahmedghorab realworldevaluationofcostsofillnessforpneumoniainadultpatientsindubaiaclaimsdatabasestudy AT mostafaelaassar realworldevaluationofcostsofillnessforpneumoniainadultpatientsindubaiaclaimsdatabasestudy AT hammamharidy realworldevaluationofcostsofillnessforpneumoniainadultpatientsindubaiaclaimsdatabasestudy AT nancyawad realworldevaluationofcostsofillnessforpneumoniainadultpatientsindubaiaclaimsdatabasestudy AT badarinathchickballapurramachandrachar realworldevaluationofcostsofillnessforpneumoniainadultpatientsindubaiaclaimsdatabasestudy AT ashoknatarajan realworldevaluationofcostsofillnessforpneumoniainadultpatientsindubaiaclaimsdatabasestudy |